Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $11.37 in the prior trading day, Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $11.30, down -0.62%. In other words, the price has decreased by -$0.62 from its previous closing price. On the day, 0.65 million shares were traded. OCUL stock price reached its highest trading level at $11.4613 during the session, while it also had its lowest trading level at $11.08.
Ratios:
Our goal is to gain a better understanding of OCUL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.55 and its Current Ratio is at 16.64. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
On June 20, 2024, TD Cowen Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $7 to $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 16 ’24 when PHILIP C. STRASSBURGER bought 13,125 shares for $10.23 per share.
Nayak Sanjay sold 1,832 shares of OCUL for $16,525 on Aug 23 ’24. The Chief Strategy Officer now owns 176,194 shares after completing the transaction at $9.02 per share. On Aug 23 ’24, another insider, Dugel Pravin, who serves as the insider of the company, sold 20,880 shares for $9.02 each. As a result, the insider received 188,338 and left with 812,473 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCUL now has a Market Capitalization of 1761918592 and an Enterprise Value of 1377113088. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.84 while its Price-to-Book (P/B) ratio in mrq is 4.66. Its current Enterprise Value per Revenue stands at 22.54 whereas that against EBITDA is -12.435.
Stock Price History:
Over the past 52 weeks, OCUL has reached a high of $11.60, while it has fallen to a 52-week low of $2.00. The 50-Day Moving Average of the stock is 23.68%, while the 200-Day Moving Average is calculated to be 51.38%.
Shares Statistics:
The stock has traded on average 1.17M shares per day over the past 3-months and 1732040 shares per day over the last 10 days, according to various share statistics. A total of 155.92M shares are outstanding, with a floating share count of 134.99M. Insiders hold about 13.42% of the company’s shares, while institutions hold 76.90% stake in the company. Shares short for OCUL as of 1727654400 were 16194368 with a Short Ratio of 13.79, compared to 1724976000 on 18351242. Therefore, it implies a Short% of Shares Outstanding of 16194368 and a Short% of Float of 10.43.
